Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: A Gynecologic Oncology Group study

Gynecologic Oncology

Volumn 121, Issue 3, 2011, Pages 542-545

  Rose, Peter G ^a,f   Ali, Shamshad ^b   Whitney, Charles W ^c   Lanciano, Rachelle ^d   Stehman, Frederick B ^e  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c CHRISTIANA CARE HEALTH SYSTEM   (United States)

^d Delaware County Memorial Hospital   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Hydronephrosis; Performance status; Stage IVA cervical cancer; Survival

Indexed keywords

CISPLATIN; FLUOROURACIL; HYDROXYUREA;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; OVERALL SURVIVAL; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; STAGE IVA CERVICAL CANCER; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR VOLUME; UTERINE CERVIX CANCER;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; HYDROXYUREA; MIDDLE AGED; MISONIDAZOLE; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 79957498485     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.02.024     Document Type: Article

References (20)

1. C.A. Perez, S. Breaux, H. Mados-Jones, J.M. Bedwinek, H.M. Camel, and J.A. Purdy Radiation therapy alone in the treatment of cancer of the cervix I. Analysis of tumor recurrence. Cancer 51 1983 1393 1402 (Pubitemid 13162133)
2. C. Kramer, R.E. Peschel, and N. Goldberg Radiation treatment of FIGO stage IVA carcinoma of the cervix Gynecol Oncol 32 1989 323 326 (Pubitemid 19074922)
3. T.L. Park, J.S. Kong, D.M. Gershenson, and M.D. McNeese Definitive radiotherapy in the treatment of carcinoma of the uterine cervix with bladder invasion Int J Radiat Oncol Biol Phys 12S1 1986 96
4. The National Cancer Institute Clinical Announcement on Cervical Cancer, February 22, 1999. http://www.nci.nih.gov/clinicaltrials/digestpage/cervical- cancer-announcement.
5. C.W. Whitney, W. Sause, B.N. Bundy, J.H. Malfetano, E.V. Hannigan, and W.C. Fowler Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. A Gynecologic Oncology Group and Southwest Oncology Group Study J Clin Oncol 17 1999 1339 1348 (Pubitemid 29220838)
6. P.G. Rose, B.N. Bundy, E.B. Watkins, J.T. Thigpen, G. Deppe, and M.A. Maiman Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1999 1144 1153 (Pubitemid 29177873)
7. H.M. Keys, B.M. Bundy, F.B. Stehman, L.I. Muderspach, and W.E. Chafe III Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1999 1154 1161 (Pubitemid 29177874)
8. M. Morris, P.J. Eifel, J. Lu, P.W. Grigsby, C. Levenback, and R.E. Stevens Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high risk cervical cancer N Engl J Med 340 1999 1137 1143 (Pubitemid 29177872)
9. W.A. Peters III, P.Y. Liu, R.J. Barrett II, R. Stock, B.J. Monk, and J.F. Berek Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606 1613 (Pubitemid 30220538)
10. F.B. Stehman, B.N. Bundy, H. Keys, J.L. Currie, R. Mortel, and W.T. Creasman A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study Am J Obstet Gynecol 159 1988 87 94
11. R. Lanciano, A. Calkins, B.N. Bundy, G. Parham, J.A. Lucci III, and D.H. Moore Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a Gynecologic Oncology Group study J Clin Oncol 23 2005 8289 8295
12. J.M. Bland, and D.G. Altman The logrank test BMJ 328 7447 2004 1073
13. J. Crowley A note on some recent likelihoods leading to the log rank test Biometrika 61 1974 533 538
14. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assn 53 1958 457 481
15. D.R. Cox Regression models and life tables J R Stat Soc 34(B) 1972 187 220
16. P.G. Rose, S. Ali, C.W. Whitney, R. Lanciano, and F.B. Stehman Impact of hydronephrosis on outcome of stage IIIB cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: a Gynecologic Oncology Group study Gynecol Oncol 117 2010 270 275
17. P.G. Rose, and B.N. Bundy Chemoradiation for locally advanced cervical cancer. Does it help? J Clin Oncol 20 2002 891 893 (Pubitemid 34141828)
18. Kosary CL. Cancer of the cervix uteri. In Monograph of Cancer, Statistics, pp 114.
19. P.G. Rose, S. Ali, E. Watkins, J.T. Thigpen, G. Deppe, and D.L. Clarke-Pearson Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy or hydroxyurea during pelvic irradiation for locally advanced cervical cancer. A Gynecologic Oncology Group study J Clin Oncol 25 2007 2804 2810 (Pubitemid 47123190)
20. M.A. Quinn, J.L. Benedet, F. Odicino, P. Maisonneuve, U. Beller, W.T. Creasman, A.P. Heintz, H.Y. Ngan, and S. Pecorelli Carcinoma of the cervix uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer Int J Gynaecol Obstet 95 Suppl 1 2006 Nov S43 103